Intramuscular Epinephrine for Anaphylaxis
Administer epinephrine 0.3-0.5 mg (adults ≥30 kg) or 0.01 mg/kg up to 0.3 mg (children <30 kg) intramuscularly into the anterolateral thigh immediately upon recognition of anaphylaxis, and repeat every 5-10 minutes as needed. 1, 2
Dosing by Weight
Adults and children ≥30 kg (66 lbs):
Children <30 kg (66 lbs):
- Dose: 0.01 mg/kg of 1:1000 epinephrine, maximum 0.3 mg per injection 2
- Autoinjector dosing:
Administration Technique
Site of injection:
- Inject into the anterolateral aspect of the mid-thigh (vastus lateralis muscle) 1, 2
- This is the ONLY recommended site—never inject into the deltoid, subcutaneous tissue, buttocks, digits, hands, or feet 1, 2
- Can be administered through clothing if necessary 4, 2
Why the lateral thigh is critical:
- Intramuscular injection in the vastus lateralis achieves peak plasma concentrations in 8±2 minutes 1, 3
- Subcutaneous injection in the deltoid takes 34±14 minutes to reach peak levels (range: 5-120 minutes), which is dangerously slow 1
- Use a needle at least 1/2 to 5/8 inch long to ensure intramuscular delivery 2
Repeat Dosing
Repeat every 5-10 minutes if:
- Symptoms persist, worsen, or recur 1, 4, 2
- No response to initial dose 1
- Approximately 7-18% of patients require more than one dose 1
Important: If EMS arrival will exceed 5-10 minutes and the patient has not responded to the initial dose, administer a repeat dose 1
Critical Timing Considerations
Epinephrine must be given FIRST—do not delay for antihistamines or corticosteroids:
- Delay in epinephrine administration is associated with anaphylaxis fatalities 3, 4, 5
- Epinephrine is most effective when given immediately after symptom onset 6
- Approximately 500-1000 people die annually in the United States from anaphylaxis 1
Concurrent Management
Immediately after epinephrine administration:
- Activate emergency medical services (call 911) 1, 4
- Position patient supine with legs elevated (unless respiratory distress prevents this) 4
- Monitor clinically for reaction severity and cardiac effects 2
Common Pitfalls to Avoid
Do NOT:
- Use subcutaneous route instead of intramuscular—this delays absorption by 26 minutes 1, 3
- Inject into the deltoid or other sites—only the lateral thigh provides rapid absorption 1
- Administer repeated injections at the same site—this causes vasoconstriction and potential tissue necrosis 2
- Delay epinephrine while giving antihistamines first—this increases mortality 3, 4, 5
- Use ampule/syringe/needle instead of autoinjector in community settings—this causes significant delays and dosing errors 3
Autoinjector dosing challenges:
- Fixed doses (0.15 mg and 0.3 mg) may result in underdosing in adolescents or overdosing in small children 1
- However, slight overdosing is preferable to underdosing during life-threatening anaphylaxis 3
- The 1.5-inch needle on autoinjectors may not reach muscle in obese adolescents 1
No Absolute Contraindications
Epinephrine has NO absolute contraindications for anaphylaxis treatment:
- Use even in patients with cardiac disease, advanced age, or frailty 3
- The risk of death from untreated anaphylaxis far exceeds the risk of epinephrine-related cardiac effects 4
- Serious adverse effects attributed to epinephrine typically follow large intravenous overdoses, not appropriate intramuscular dosing 1
Post-Treatment Requirements
All patients must: